Titles and Roles
- Assistant Professor, Department of Radiation Oncology
- Emory University School of Medicine
- Research Program
- Cancer Genetics and Epigenetics
Michael R. Rossi, PhD, is an Assistant Professor in the Department of Radiation Oncology at Emory Univeristy School of Medicine. Dr. Rossi is dual-board certified in molecular genetics and cytogenetics by the American Board of Medical Genetics and serves in leadership roles at Emory and nationally for clinical cancer genomics applications in lung cancer and hematological malignancies through the Lung Cancer Mutation Consortium and the Cancer Genomics Consortium. He is a member of the Cancer Genetics and Epigenetics Research Program at Winship Cancer Institute.
Dr. Rossi received his PhD in Genetics and Developmental Biology from West Virginia University and his BS in Biology from St. Joseph's University in Philadelphia, PA. His postdoctoral training includes a Basic Science Postdoctoral Fellowship for the Department of Cancer Genetics at Roswell Park Cancer Institute (2002-2005) and Clinical Molecular Genetics and Cytogenetics Fellowships for the Department of Genetics at Yale University (2005-2008).
His laboratory has been at the forefront of next generation sequencing and microarray technology development for cancer diagnostics and cancer research. They have developed whole exome, custom cancer exome, whole transcriptome (RNA-Seq) and whole genome workflows for the Illumina HiSeq, as well as high throughput deep sequencing panels for FFPE tumor samples using Illumina TruSight Tumor and custom Fluidigm Access Array library preps with the Illumina MiSeq instrument. These assays are developed to better characterize cancer subtypes to predict therapeutic response, and the Rossi lab has a variety of clinical and basic science collaborations to pursue the biology and clinical implications of somatic mutations and structural abnormalities that drive various cancer processes.